Comparing two injection devices for a new study drug
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests two different ways to inject the same study drug (called SHR-1703) in healthy people. It compares a pre-filled syringe with an autoinjector to see if they deliver the drug equally well and are safe to use. If you join, you'll be helping researchers learn which injection method is easier and more reliable for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 19 and 26, and you must weigh between 50 and 80 kg.
- You must be in good general health, with no active or chronic diseases, and no significant abnormalities on blood tests, heart tests, or chest X-ray.
- You must avoid pregnancy (or fathering a child) and use effective birth control for up to 14 months after the study drug is given.
- You must be a non-smoker or smoke fewer than 5 cigarettes per day, and not abuse alcohol or drugs.
- You cannot have taken most medicines, vaccines, or participated in another trial recently (within a month to 3 months, depending on the product).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests a new medicine called SHR-1703 for people with eosinophilic asthma (a type of asthma with high levels of certain white blood cells). It looks at how safe the medicine is over time and if it helps control asthma attacks. You must already be using medium or high dose inhaled steroids plus another asthma medicine, and have had at least one asthma attack in the past year.
This trial tests an experimental drug called SHR-1905 for people with severe asthma that is not well controlled by their current treatments. The study aims to see if the drug can reduce asthma attacks and improve breathing.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
This trial tests an experimental medication called SIM0718 to see if it can improve asthma control and reduce flare-ups. It may be an option for people whose asthma is not well-controlled with their current inhaler therapy.
This study tests a new injected medicine, RC1416, for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It aims to see if the treatment can reduce asthma attacks and improve breathing.
Hear when a new Asthma With Eosinophilic Phenotype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.